Form D · Biotechnology
Toggle Bio
Durham, NC · CIK 0002158695
Offering snapshot reported Oct 6, 2026 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- May 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 6, 2026 | Initial | $200,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600048
SAFEs
Source: Form D, filed Oct 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sean M Burrows | Director, Executive |
| Craig D La Boda | Director, Executive |
| Nicholas K Pinkin | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
701 West Main Street Suite 200
Durham, NC, 27701
Phone: 860-967-4787
Durham, NC, 27701
Phone: 860-967-4787